How old is old: the beginning of a new era for therapeutic challenges for elderly patients with AML-Reference-Cited by-同舟云学术

How old is old: the beginning of a new era for therapeutic challenges for elderly patients with AML

Published:2014 Issue:2 Volume:49 Page:75
ISSN:2287-979X
Container-title:Blood Research
language:en
Short-container-title:Blood Res

Author:

Kim Hee-Je¹

Affiliation:

1. Division of Hematology, Department of Internal Medicine, Cancer Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Publisher

The Korean Society of Hematology

Subject

Hematology

Link

https://synapse.koreamed.org/pdf/10.5045/br.2014.49.2.75

Reference10 articles.

1. National Cancer Institute. The SEER Program. Bethesda, MD. National Institutes of Health. 2012. Accessed June 17, 2014. at http://seer.cancer.gov/about/

2. Survival for older patients with acute myeloid leukemia: a population-based study

3. To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century

4. Older Patients With Acute Myeloid Leukemia Benefit From Intensive Chemotherapy: An Update From the Swedish Acute Leukemia Registry

5. Intensive chemotherapy for elderly patients with acute myelogeneous leukemia: a propensity score analysis by the Japan Hematology and Oncology Clinical Study Group (J-HOCS)

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced intensity conditioning of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia in patients older than 50 years of age: a systematic review and meta-analysis;Journal of Cancer Research and Clinical Oncology;2017-05-03